PharmiWeb.com - Global Pharma News & Resources
13-Dec-2018

The synthetic stem cells market is expected to grow from USD 14 million in 2023 to USD 37 million by 20283, at a CAGR of 22.5%

The synthetic stem cells market is expected to grow from USD 14 million in 2023 to USD 37 million by 20283, at a CAGR of 22.5%

PR Newswire

NEW YORK, Dec. 12, 2018

NEW YORK, Dec. 12, 2018 /PRNewswire/ -- Ethical concerns regarding embryonic stem cells is expected to drive the overall growth of the synthetic stem cells market.

Read the full report: https://www.reportlinker.com/p05652527

The synthetic stem cells market is expected to grow from USD 14 million in 2023 to USD 37 million by 20283, at a CAGR of 22.5% during the forecast period. The synthetic stem cells market is driven by various factors such as ethical concerns regarding embryonic stem cells and the risk of tumor formation and immune rejection of natural stem cells. However, the unclear and unstructured regulations on the use of synthetic stem cells can hinder the growth of the market.

The neurological disorders segment is expected to witness the highest CAGR during the forecast period.
The neurological disorders application is the faster-growing segment in the overall synthetic stem cells market. Based on application, the synthetic stem cells market is segmented into cardiovascular diseases, neurological disorders, and other diseases that include various cancers, wounds and injuries, musculoskeletal disorders, and blood disorders that require regenerative therapies.

North America is expected to record the highest growth rate during the forecast period.
Countries in North America are constantly modernizing their healthcare infrastructure by investing in advanced therapies. The increasing prevalence of target diseases, focus on development of for regenerative medicines, fast adoption of advanced therapies, and regulatory support for stem cell therapies will result in the high rate of adoption of synthetic stem cell therapies in this region by 2023.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, innovation and technology directors, and executives from various key organizations operating in the synthetic stem cells market.
•?By Company Type: Tier 1: 42%, Tier 2: 37%, and Tier 3: 21%
•?By Designation: C-level Executives: 34%, Directors: 42%, and Others: 24%
•?By Region: North America: 32%, Europe: 30%, APAC: 24%, and RoW: 14%

The synthetic stem cells market comprises two major providers, namely, North Carolina State University (NCSU) (US) and Zhengzhou University (China).

Research Coverage:
This market study covers the synthetic stem cells market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on application and region.

Key Benefits of Buying the Report:
The report will provide the market leaders/new entrants in this market with information on the closest approximations of the revenue of the overall synthetic stem cells market and its subsegments.This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies.

The report will also help stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

Read the full report: https://www.reportlinker.com/p05652527

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/the-synthetic-stem-cells-market-is-expected-to-grow-from-usd-14-million-in-2023-to-usd-37-million-by-20283--at-a-cagr-of-22-5-300764332.html

SOURCE Reportlinker

Editor Details

Last Updated: 13-Dec-2018